FIELD: medicine, bacteriology. SUBSTANCE: invention proposes carrying out the diagnosis among chronic and residual, chronic and primary-chronic, primary-chronic and latent forms of brucellosis. Chronic form is diagnosed at the following indices of enzyme activity (by Keplou units): myeloperoxidase 2.48-2.94; nonspecific esterase 2.54-2.94; alkaline phosphatase 0.6-1.0; cationic protein 2.1-2.42. Residual form: 1.82-2.06; 1.3-1.69; 0.37-0.89; 2.03-2.23, respectively. Primary-chronic form: 2.88-2.98; 1.0-1.8; 0.34-0.5; 2.05-2.25, respectively. Latent form: 2.15-2.25; 1.93-2.63; 0.71-0.81 and 1.6-2.0, respectively. EFFECT: enhanced reliability of diagnosis.
Title | Year | Author | Number |
---|---|---|---|
METHOD TO CONTROL EPIZOOTOLOGOEPIDEMIOLOGICAL STATE ON BRUCELLOSIS IN ANIMAL FARMS | 2000 |
|
RU2180751C2 |
METHOD OF COUPLED ESTIMATION OF FUNCTIONAL ACTIVITY OF PERIPHERAL BLOOD NEUTROPHILS AT BRUCELLOSIS PATHOGEN EFFECT | 1997 |
|
RU2133471C1 |
METHOD FOR CONTROL OF ANTIBIOTIC EFFICIENCY IN TREATMENT OF BRUCELLOSIS | 2001 |
|
RU2206898C2 |
METHOD OF SELECTION OF WHITE MICE AND GOLDEN HAMSTERS FOR MODELLING OF EXPERIMENTAL PLAGUE INFECTION | 2007 |
|
RU2335766C1 |
METHOD FOR EVALUATING OF DESINTOXICATION THERAPY EFFICIENCY UNDER ACTION OF TOXINS OF VARIOUS NATURE | 2007 |
|
RU2334989C1 |
METHOD FOR DIFFERENTIATING IN VITRO POSTVACCINAL AND INFECTIOUS BRUCELLOSIS ACCORDING TO DEGREE OF BODY HYPERSENSITIVITY TO BRUCELLA | 2015 |
|
RU2574207C1 |
METHOD FOR TREATMENT OF BRUCELLOSIS | 2002 |
|
RU2234311C1 |
METHOD FOR TREATMENT OF BRUCELLOSIS | 2002 |
|
RU2239416C2 |
METHOD FOR DIAGNOSTICS OF SYPHILIS (VARIANTS) | 1999 |
|
RU2200327C2 |
METHOD OF ANTIGEN PREPARING FOR BRUCELLOSIS DIAGNOSIS | 1997 |
|
RU2133470C1 |
Authors
Dates
1998-01-27—Published
1995-04-11—Filed